CA
Congress trade
Rep. Cindy Axne (D-IA) sold $1K-$15K of Johnson & Johnson (JNJ) stock
Cindy Axne, U.S. Representative (D-IA), disclosed a sale of Johnson & Johnson (JNJ) stock worth $1K-$15K in a STOCK Act filing on Oct 8, 2021.
The trade happened on Apr 21, 2020, 535 days before it was made public.
JNJ has moved +71.1% since the trade date, from $149.68 to $256.03 (Oct 2, 2026 close).
- Traded
- Apr 21, 2020
- Disclosed
- Oct 8, 2021
- Filing delay
- 535 days
- Price since
- +71.1%
- Source
- STOCK Act disclosure
Other trades in this disclosure (60)
- BuyAMT$1K-$15KOct 8, 2021
- BuyAMZN$1K-$15KOct 8, 2021
- BuyAMZN$1K-$15KOct 8, 2021
- BuyAMZN$1K-$15KOct 8, 2021
- BuyAMZN$1K-$15KOct 8, 2021
- BuyAMZN$1K-$15KOct 8, 2021
- BuyAZO$1K-$15KOct 8, 2021
- BuyAZO$1K-$15KOct 8, 2021
- BuyAZO$1K-$15KOct 8, 2021
- BuyAZO$1K-$15KOct 8, 2021
- SellCERN$1K-$15KOct 8, 2021
- SellCERN$1K-$15KOct 8, 2021
- SellCERN$1K-$15KOct 8, 2021
- BuyCVET$1K-$15KOct 8, 2021
- BuyCVET$1K-$15KOct 8, 2021
- BuyCVET$1K-$15KOct 8, 2021
- SellFRFHF$1K-$15KOct 8, 2021
- SellFRFHF$1K-$15KOct 8, 2021
- SellITW$1K-$15KOct 8, 2021
- SellITW$1K-$15KOct 8, 2021
More JNJ insider and Congress trades
From a public STOCK Act disclosure, linked above. Not investment advice, and not a recommendation to buy or sell.